Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma

Rodrigo Carlini Fernando1, Fabrício de Carvalho1, Adriana Franco Paes Leme2

  • 1Department of Experimental and Clinical Oncology, Discipline of Hematology and Hemotherapy, Federal University of São Paulo, UNIFESP, São Paulo, Brazil.

Frontiers in Oncology
|April 9, 2021
PubMed

Insights

This study compared bone marrow cells from multiple myeloma (MM) patients and healthy individuals. MM patients showed increased protein biosynthesis and energy metabolism, alongside impaired immune responses, highlighting new therapeutic targets for this incurable cancer.

Area of Science:

  • Oncology
  • Proteomics
  • Cancer Biology

Background:

  • The "seed and soil" hypothesis highlights the tumor microenvironment's role in metastasis.
  • Multiple myeloma (MM) bone marrow microenvironment is crucial for cancer cell survival and drug resistance.
  • Despite therapeutic advances, MM remains incurable, necessitating further research into its pathophysiology.

Purpose of the Study:

  • To investigate protein expression profiling in bone marrow mononuclear cells from MM patients versus healthy individuals.
  • To identify dysregulated biological pathways and processes in the MM bone marrow microenvironment.
  • To uncover potential new therapeutic targets for MM treatment.

Main Methods:

  • Proteomic analysis using mass spectrometry.
  • Bioinformatic tools for pathway and process analysis.
  • Comparison of protein expression between MM patients and healthy controls.

Main Results:

  • Upregulation of proteins involved in protein biosynthesis, particularly chaperone proteins, in MM patients.
  • Increased expression of proteins related to energy metabolism, a hallmark of cancer.
  • Downregulation of proteins associated with immune response pathways, indicating immune impairment in MM.

Conclusions:

  • The bone marrow microenvironment in MM exhibits altered protein expression, including enhanced protein synthesis and energy metabolism.
  • Impaired immune responses in MM patients underscore the need for immunotherapies.
  • These findings provide insights into MM pathophysiology and suggest potential therapeutic strategies.